These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 11106149)

  • 1. Mecamylamine increases cigarette smoking in psychiatric patients.
    Marx CE; McIntosh E; Wilson WH; McEvoy JP
    J Clin Psychopharmacol; 2000 Dec; 20(6):706-7. PubMed ID: 11106149
    [No Abstract]   [Full Text] [Related]  

  • 2. Effects of acute abstinence, reinstatement, and mecamylamine on biochemical and behavioral measures of cigarette smoking in schizophrenia.
    Weinberger AH; Sacco KA; Creeden CL; Vessicchio JC; Jatlow PI; George TP
    Schizophr Res; 2007 Mar; 91(1-3):217-25. PubMed ID: 17293085
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A preliminary study of the effects of cigarette smoking on prepulse inhibition in schizophrenia: involvement of nicotinic receptor mechanisms.
    George TP; Termine A; Sacco KA; Allen TM; Reutenauer E; Vessicchio JC; Duncan EJ
    Schizophr Res; 2006 Oct; 87(1-3):307-15. PubMed ID: 16854565
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of the nicotinic receptor antagonist mecamylamine on ad-lib smoking behavior, topography, and nicotine levels in smokers with and without schizophrenia: a preliminary study.
    McKee SA; Weinberger AH; Harrison EL; Coppola S; George TP
    Schizophr Res; 2009 Dec; 115(2-3):317-24. PubMed ID: 19700263
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mecamylamine blocks nicotine-induced enhancement of the P20 auditory event-related potential and evoked gamma.
    Phillips JM; Ehrlichman RS; Siegel SJ
    Neuroscience; 2007 Feb; 144(4):1314-23. PubMed ID: 17184927
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of cigarette smoking on spatial working memory and attentional deficits in schizophrenia: involvement of nicotinic receptor mechanisms.
    Sacco KA; Termine A; Seyal A; Dudas MM; Vessicchio JC; Krishnan-Sarin S; Jatlow PI; Wexler BE; George TP
    Arch Gen Psychiatry; 2005 Jun; 62(6):649-59. PubMed ID: 15939842
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neuronal nicotinic receptor inhibition for treating mood disorders: preliminary controlled evidence with mecamylamine.
    Shytle RD; Silver AA; Sheehan KH; Sheehan DV; Sanberg PR
    Depress Anxiety; 2002; 16(3):89-92. PubMed ID: 12415531
    [No Abstract]   [Full Text] [Related]  

  • 8. Acute effects of nicotine and mecamylamine on tobacco withdrawal symptoms, cigarette reward and ad lib smoking.
    Rose JE; Behm FM; Westman EC
    Pharmacol Biochem Behav; 2001 Feb; 68(2):187-97. PubMed ID: 11267622
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Different physiological and behavioural effects of e-cigarette vapour and cigarette smoke in mice.
    Ponzoni L; Moretti M; Sala M; Fasoli F; Mucchietto V; Lucini V; Cannazza G; Gallesi G; Castellana CN; Clementi F; Zoli M; Gotti C; Braida D
    Eur Neuropsychopharmacol; 2015 Oct; 25(10):1775-86. PubMed ID: 26141510
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nicotine-mecamylamine interactions.
    Zevin S; Jacob P; Benowitz NL
    Clin Pharmacol Ther; 2000 Jul; 68(1):58-66. PubMed ID: 10945316
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neurochemical and behavioral effects of bupropion and mecamylamine in the presence of nicotine.
    Vann RE; Rosecrans JA; James JR; Philibin SD; Robinson SE
    Brain Res; 2006 Oct; 1117(1):18-24. PubMed ID: 16949560
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nicotinic receptor involvement in antinociception induced by exposure to cigarette smoke.
    Simons CT; Cuellar JM; Moore JA; Pinkerton KE; Uyeminami D; Carstens MI; Carstens E
    Neurosci Lett; 2005 Dec; 389(2):71-6. PubMed ID: 16095820
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mecamylamine blockade of both positive and negative effects of IV nicotine in human volunteers.
    Lundahl LH; Henningfield JE; Lukas SE
    Pharmacol Biochem Behav; 2000 Jul; 66(3):637-43. PubMed ID: 10899382
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Behavioral and biochemical manifestations of mecamylamine-precipitated nicotine withdrawal in the rat: role of nicotinic receptors in the ventral tegmental area.
    Hildebrand BE; Panagis G; Svensson TH; Nomikos GG
    Neuropsychopharmacology; 1999 Oct; 21(4):560-74. PubMed ID: 10481840
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mecamylamine acutely increases human intravenous nicotine self-administration.
    Rose JE; Behm FM; Westman EC; Bates JE
    Pharmacol Biochem Behav; 2003 Sep; 76(2):307-13. PubMed ID: 14592683
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of the nicotinic antagonist mecamylamine on inspection time.
    Thompson JC; Stough C; Ames D; Ritchie C; Nathan PJ
    Psychopharmacology (Berl); 2000 May; 150(1):117-9. PubMed ID: 10867984
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nicotine withdrawal hyperalgesia and opioid-mediated analgesia depend on nicotine receptors in nucleus accumbens.
    Schmidt BL; Tambeli CH; Gear RW; Levine JD
    Neuroscience; 2001; 106(1):129-36. PubMed ID: 11564423
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of varenicline and mecamylamine on the acquisition, expression, and reinstatement of nicotine-conditioned place preference by drug priming in rats.
    Biala G; Staniak N; Budzynska B
    Naunyn Schmiedebergs Arch Pharmacol; 2010 Apr; 381(4):361-70. PubMed ID: 20217050
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The role of nicotinic acetylcholine receptors in the primary reinforcing and reinforcement-enhancing effects of nicotine.
    Palmatier MI; Liu X; Caggiula AR; Donny EC; Sved AF
    Neuropsychopharmacology; 2007 May; 32(5):1098-108. PubMed ID: 17091131
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of both alpha7* and beta2* nicotinic acetylcholine receptors is necessary to prevent development of sensitization to cocaine-elicited increases in extracellular dopamine levels in the ventral striatum.
    Zanetti L; de Kerchove D'Exaerde A; Zanardi A; Changeux JP; Picciotto MR; Zoli M
    Psychopharmacology (Berl); 2006 Aug; 187(2):181-8. PubMed ID: 16826402
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.